The goal of this clinical research study is to learn if the drug nesiritide (Natrecor) is
effective in lowering the pressure in your lungs.
The primary objective of this study is to establish that Nesiritide (Natrecor) is effective
in reducing pulmonary hypertension (PHTN) acutely as measured by a 20% reduction in the mean
pulmonary arterial (PA) pressure. The secondary objectives will include: improvement in
pulmonary vascular resistance (PVR), patient symptoms, exercise tolerance, frequency of
toxicity, and surgeon's willingness to proceed with operation.
Use of Nesiritide in the Management of Acute Diastolic Heart Failure
Terminated
M.D. Anderson Cancer Center
Phase 4
2004-05-17
Primary objective is to assess the effect of nesiritide in decreasing left ventricular (LV)
filling pressure, defined as pulmonary artery capillary wedge pressure (PCWP) in a group of
patients admitted with acute diastolic heart failure.
Secondary objectives include: improvement in symptoms, exercise tolerance, improvement in
Doppler diastolic filling parameters in patients with diastolic heart failure.
A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure
Completed
Scios, Inc.
Phase 2
2004-04-01
The purpose of this study is to evaluate the efficacy and safety of Nesiritide administered
as serial infusions to heart failure (HF) patients in the outpatient setting.
Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction
Completed
Scios, Inc.
Phase 2
2003-04-01
The researchers hypothesize that the addition of nesiritide to standard therapy will prevent
worsening of renal function in patients admitted to the hospital with decompensated heart
failure and renal dysfunction relative to standard therapy alone.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
